HepCommJournal Profile Banner
Hepatology Communications Profile
Hepatology Communications

@HepCommJournal

Followers
8K
Following
1K
Media
640
Statuses
2K

Hepatology Communications: Official open access journal of the AASLD (@AASLDtweets)| Co-editors in Chief: @ebtapper and Dr. Wong| #SoMe Editor: @jlouissaint89

Alexandria, VA
Joined April 2019
Don't wanna be here? Send us removal request.
@HepCommJournal
Hepatology Communications
6 months
🚨GI/Hep Fellowships start next week‼️ @HepCommJournal has the 📑 you need to thrive 💫 #GIHepFellowshipBootcamp First up, you get a consult for a #LiverMass, ✅ out this review about benign liver masses❕ 📍Hemangiomas 📍FNH 📍Hepatic Adenomas 📍Cysts https://t.co/4UEGFrMO8U
1
95
213
@HepCommJournal
Hepatology Communications
2 months
📑 The current applications and future directions of #terlipressin‼️ https://t.co/CxaXLiq3Nu
1
34
81
@PressCompassion
Children Who Dance in the Rain
2 months
From her comfortable life in America, Sophie plunges into India's colorful slums in 'Children Who Dance in the Rain.' Her transformative journey uncovers magic, gratitude, and empathy. Your purchase writes new stories -- 25% of proceeds directly aid underprivileged children.
11
20
333
@HepCommJournal
Hepatology Communications
20 days
📑 Noninvasive pathway for stratifying fibrosis in suspected #MetALD❗️ #LiverX #OpenAccess https://t.co/XJkT9Tsk47
0
25
64
@rabataller
Ramon Bataller
14 days
A meta-analysis shows that in liver disease due to alcohol use, psychosocial therapy reduces return-to-drinking by ~50%: 👉 Treating AUD in CLD is NOT just about prescribing pills. 👉 Psychosocial therapy + pharmacotherapy = best outcomes. Offer both ! https://t.co/Enl66kRowV
2
33
61
@HepCommJournal
Hepatology Communications
19 days
📑 Hepatobiliary complications in patients with #SickleCellDisease: A 30-year review of 1009 patients‼️ #LiverX #OpenAccess https://t.co/2RbLg5GdD4
0
13
43
@Chevron
Chevron
28 days
Our investment strategy focuses on long-term value, not short-term price swings. Our Chairman & CEO Mike Wirth explains how disciplined investment drives long-term value.
10
7
98
@HepCommJournal
Hepatology Communications
19 days
📑 Awareness of #MASLD in 4 major cities in the United States 🇺🇸 is LOW‼️ https://t.co/Oycis0bEuq
1
14
22
@HepCommJournal
Hepatology Communications
20 days
📑 #Cholangiocarcinoma cells direct fatty acids to support membrane synthesis and modulate macrophage phenotype❕ https://t.co/rkUTqYD7sa
0
4
14
@HepCommJournal
Hepatology Communications
20 days
📑 Noninvasive pathway for stratifying fibrosis in suspected #MetALD❗️ #LiverX #OpenAccess https://t.co/XJkT9Tsk47
0
25
64
@HepCommJournal
Hepatology Communications
2 months
📑 Evidence-based criteria for identifying at-risk individuals requiring #liver disease screening 🔍 https://t.co/DFSXgSkJ29
1
17
47
@DoxaseCo
Doxase
1 month
No more soggy bath mats — this super absorbent floor rug locks in moisture fast, dries quickly, and stays firmly in place for safer steps every day.
0
2
15
@ebtapper
Elliot Tapper
27 days
Porphyria pearls An open access review on everything you need to know about the porphyrias https://t.co/XiR2OGFHBL
0
60
164
@LiverFellow
Liver Fellow Network
1 month
💥 Record-breaking participation this year for #HepMadness2025! 🏆 Final votes are in - The Winners are: 1st @McNultyRDO 22 points 2nd @dr_rishikaT 18 points 3rd nappillai 15 points 🏆 The winning bracket - “The Rise of AI”
2
6
26
@ebtapper
Elliot Tapper
1 month
Standing room only for community conversations with editors @AASLDtweets journals
1
2
23
@ebtapper
Elliot Tapper
1 month
Do you also dream of preventing liver cancer? Must read: https://t.co/10KR8hSU8h
2
36
102
@sumikko_allgame
Sumikkogurashi 【Switch】
3 days
NintendoSwitch 《Sumikkogurashi Create a Wonderful Sumikko Island!》 If you love it, Like and Repost! 👇Click here for Nintendo eshop
1
7
271
@ebtapper
Elliot Tapper
1 month
Neehar made me respect AFP, among the many things he has taught me (I recommend his recent editorial, fig 1) So I asked him, maybe should we have a review just on AFP? he said, yes, from @JuDongYang1 https://t.co/OMORnM6JnS It is a masterclass (fig 2)
1
21
75
@HepCommJournal
Hepatology Communications
6 months
🚨 Liver Biopsy remains a 🔑 tool in our 🧰 , so #GIHepFellowshipBootcamp is here to get you ready to understand: 💉Utility of biopsy across conditions❕ 💉Biopsy histologic characteristics❕ 💡The table below is GOLD 🏆 https://t.co/eUOMCGDjdN
1
71
158
@HepCommJournal
Hepatology Communications
4 months
📑 Unraveling enhanced liver regeneration in ALPPS: Integrating multi-omics profiling and in vivo CRISPR in mouse models https://t.co/gvBQAy8WeR
0
2
10
@HepCommJournal
Hepatology Communications
4 months
📑 Natural language processing to detect steatotic liver disease from the EHR is fast, scalable, and highly accurate‼️ AI is transforming liver disease detection ➡️ intervention❕ @bkyalwazi @jlouissaint89 #LiverTwitter #AI #NLP #SLD https://t.co/Vl9zy9hjhZ
Tweet card summary image
journals.lww.com
An abstract is unavailable.
1
6
14
@ebtapper
Elliot Tapper
2 months
It is on
@LiverFellow
Liver Fellow Network
2 months
⭐ IT’S BACK — #HepMadness2025 IS HERE! ⭐ The ultimate hepatology showdown where landmark liver papers go head-to-head for the crown 🧠 Build your bracket. 📋 Cast your votes. 🎉 Join the madness! 👉 https://t.co/bUctZdpQWo @AASLDtweets | @LiverFellow
1
2
17
@RangeETFs
Range ETFs
1 month
AI's appetite for power is rewriting the energy landscape - and nuclear is ready to deliver. Discover how innovation can meet opportunity with $NUKZ.
0
1
11
@AASLDtweets
AASLD
1 month
Did you know?📈 All #AASLD journals are in Quartile 1 in Gastroenterology & #Hepatology for 2024: HEPATOLOGY: 16.8 Hepatology Comm: 4.6 Liver Transplantation: 4.2 Our journals’ influence continues to grow. Read the latest groundbreaking #research: https://t.co/SiBOD7pgar
2
6
19
@HepCommJournal
Hepatology Communications
4 months
📑 Information overload, financial constraints, and psychological burdens are among the barriers faced by marginalized groups seeking curative treatments for #HCC‼️ https://t.co/qt9sdy2Zym
2
8
15